News reports

National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.

Immunotherapy drug too costly for head and neck cancer

An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.

Study suggests why an immunotherapy drug works in some melanoma patients but not in others

Matching tumour size to the body’s immune response could help doctors tailor immunotherapy treatments for melanoma patients whose disease has spread.

Breast cancer drug approved for use in Scotland, though concerns remain about patients getting the drug across the UK

Scotland is first part of the UK to make a drug routinely available on the NHS that can extend the lives of women with an aggressive form of breast cancer.

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

NHS cancer waiting time targets missed in Northern Ireland

Three key waiting time targets for cancer patients in Northern Ireland have been missed, according to the latest figures.

Pages